Nonoxynol-9 Labeling Changes Under Discussion At FDA
This article was originally published in The Tan Sheet
Executive Summary
Modifications of nonoxynol-9 (N-9) labeling are being considered by FDA, but the spermicide's OTC status appears to be safe for the time being
You may also be interested in...
Vaginal Contraceptive N-9 Label Warnings Urged “As Soon As Possible” – FDA
Manufacturers of vaginal contraceptives containing nonoxynol-9 should voluntarily implement proposed label warnings about increased vaginal irritation and HIV infection risk "as soon as possible," FDA advises in a 1Jan. 16 proposed rule
Vaginal Contraceptive N-9 Label Warnings Urged “As Soon As Possible” – FDA
Manufacturers of vaginal contraceptives containing nonoxynol-9 should voluntarily implement proposed label warnings about increased vaginal irritation and HIV infection risk "as soon as possible," FDA advises in a 1Jan. 16 proposed rule
Vaginal Contraceptive N-9 Label Warnings Urged “As Soon As Possible” – FDA
Manufacturers of vaginal contraceptives containing nonoxynol-9 should voluntarily implement proposed label warnings about increased vaginal irritation and HIV infection risk "as soon as possible," FDA advises in a 1Jan. 16 proposed rule